MeSH D020152 - antithrombin iii deficiency
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Laboratoire Francais du Fractionnement et des Biotechnologies S.A. | Antithrombin alfa | ATryn | 2006-07-28 |
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
100%1/1
Phase 3
100%1/1
Approved: 0Overall Success rate: 100%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use